Reliability of a terbinafine agar containing method for the screening of dermatophyte resistance
Medical Mycology · 2023
DOI: 10.1093/mmy/myad043 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Medical Mycology, 2023. Verfasst von Anne-Laure Bidaud und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unité de Parasitologie-Mycologie, Service de Microbiologie, Hôpital Européen Georges-Pompidou, AP-HP, Paris 75015, France. Hauptthemen laut MEDLINE: Antifungal Agents, Arthrodermataceae. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Gilead, MSD, Pfizer.
Abstract (Originalsprache)
The increase in terbinafine resistance worldwide due to Trichophyton indotineae underlies the need for surveillance networks, deploying easy to perform methods to correctly identify resistant isolates and thereby reduce their spread. In the present study, we evaluated the performances of the terbinafine containing agar method (TCAM). Different technical parameters, such as culture medium (RPMI agar [RPMIA] or Sabouraud dextrose agar [SDA]) and inoculum size, were evaluated. Our study showed that terbinafine susceptibility determined using the TCAM was reliable and independent of the inoculum or medium used. We then performed a multicenter, blinded study. 5 isolates of T. indotineae and 15 of genotype I or II of T. interdigitale, including 5 terbinafine-resistant isolates (4 T. indotineae and 1 T. interdigitale), were sent to eight clinical microbiology laboratories. Each laboratory analyzed the 20 isolates’ terbinafine susceptibility by the TCAM using both culture media. TCAM allowed all participants to correctly determine the terbinafine susceptibility of analyzed isolates without prior training. All participants agreed that the dermatophyte tested, regardless of species or genotype, grew better on SDA than on RPMIA medium but accumulated fungal growth after 14 days eventually minimized the effect of this difference. In conclusion, TCAM is a reliable, easy to perform screening method for assessing terbinafine resistance. However, despite good performances, TCAM is a qualitative method and minimal inhibitory concentrations must be determined by the European Committee for Antimicrobial Susceptibility Testing standardized method to follow the evolution of terbinafine resistance levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unité de Parasitologie-Mycologie, Service de Microbiologie, Hôpital Européen Georges-Pompidou, AP-HP, Paris 75015, France.
- Faculté de Médecine, Université Paris Cité, Paris 75006, France.
- Service de Parasitologie-Mycologie, Hôpital La Pitié-Salpêtrière, AP-HP, Paris 75013, France.
- Service de Parasitologie-Mycologie, Hôpital Saint Antoine, AP-HP, Paris 75013, France.
- Service de Parasitologie-Mycologie, Hôpital Avicenne, AP-HP, Bobigny 93009, France.
- Service de Parasitologie-Mycologie, Hôpital Saint Louis AP-HP, Paris 75010, France.
ORCID-Profile: Anne-Cécile Normand, Alicia Moreno-Sabater
Förderung
- Gilead
- MSD
- Pfizer
- Astellas Pharma US
Zitieren
APA
Bidaud, A. L., Normand, A. C., Jabet, A., Brun, S., Delliere, S., Cremer, G., Foulet, F., Ayachi, A., Imbert, S., Hennequin, C., Dannaoui, É., & Moreno-Sabater, A. (2023). Reliability of a terbinafine agar containing method for the screening of dermatophyte resistance. Medical Mycology. https://doi.org/10.1093/mmy/myad043
Vancouver
Bidaud AL, Normand AC, Jabet A, Brun S, Delliere S, Cremer G, et al. Reliability of a terbinafine agar containing method for the screening of dermatophyte resistance. Medical Mycology. 2023. doi:10.1093/mmy/myad043
BibTeX
@article{Bidaud2023,
author = {Bidaud, Anne-Laure and Normand, Anne-Cécile and Jabet, Arnaud and Brun, Sophie and Delliere, Sarah and Cremer, Geneviève and Foulet, Françoise and Ayachi, Aymen and Imbert, Sébastien and Hennequin, Christophe and Dannaoui, Éric and Moreno-Sabater, Alicia},
title = {Reliability of a terbinafine agar containing method for the screening of dermatophyte resistance},
journal = {Medical Mycology},
year = {2023},
doi = {10.1093/mmy/myad043}
}
EUVIMED